| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth | Usage # |
|---|
| fhir.nwgenomics.nhs.uk | R4 | ValueSet/ValueSet-OrganisationLancashireAndSouthCumbria.json | Organisation Lancashire and South Cumbria ICS (QE1) NHS Trusts | draft | | | 2026-03 | hl7 | |
| fhir.nwgenomics.nhs.uk | R4 | ValueSet/ValueSet-OrganisationNorthWest.json | Organisation North West Region NHS Trusts | draft | | | 2026-03 | hl7 | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7943.json | Data Reporting Source (COVID-19) | active | | | 2020-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.990.json | Specimen Handling Code | active | | | 2008-01 | | |
| hl7.fhir.us.directory-query | R4 | ValueSet/ValueSet-SpecialtyAndDegreeLicenseCertificateVS.json | Specialties, Degrees, Licenses, and Certificates Value Set | active | | | 2022-12 | hl7 | |
| hl7.fhir.us.davinci-pdex-plan-net | R4 | ValueSet/ValueSet-SpecialtyAndDegreeLicenseCertificateVS.json | Specialties, Degrees, Licenses, and Certificates VS | trial-use | | fm | 2025-02 | hl7 | 2 |
| hl7.fhir.us.ndh | R4 | ValueSet/ValueSet-SpecialtyAndDegreeLicenseCertificateVS.json | Specialties, Degrees, Licenses, and Certificates Value Set | trial-use | 4 | pa | 2026-03 | hl7 | 1 |
| hl7.fhir.us.ndh.r4b | R4B | ValueSet/ValueSet-SpecialtiesVS.json | Specialties Value Set | trial-use | | pa | 2025-04 | hl7 | |
| hl7.fhir.us.directory-query | R4 | ValueSet/ValueSet-SpecialtiesVS.json | Specialties Value Set | active | | | 2022-12 | hl7 | 3 |
| hl7.fhir.us.davinci-pdex-plan-net | R4 | ValueSet/ValueSet-SpecialtiesVS.json | Specialties VS | trial-use | | fm | 2025-02 | hl7 | 3 |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7836.json | Organism (TBRD) | active | | | 2018-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.8010.json | Organism Name (Brucellosis) | active | | | 2020-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.3313.json | Species (Malaria) | active | | | 2010-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.3066.json | Bat Species (Animal Rabies) | active | | | 2008-01 | | |
| hl7.fhir.us.registry-protocols | R4 | ValueSet/ValueSet-VentricularSupportDeviceType.json | Ventricular Support Device Type | active | | cic | 2023-11 | hl7 | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.876.json | Detailed Race | active | | | 2008-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.823.json | Referral Reason (HL7) | active | | | 2008-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.3023.json | Immunization Body Site | active | | | 2008-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7697.json | Birth Location (RIBD) | active | | | 2018-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.3040.json | Isolate Not Available EIP Test Reason | active | | | 2008-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.3042.json | Isolate Not Sent To NARMS Reason | active | | | 2008-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.3041.json | Isolate Not Received Reason | active | | | 2008-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.3080.json | Eosin Units (FDD) | active | | | 2008-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7837.json | Coinfection Type (TBRD) | active | | | 2018-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7668.json | Meat Consumed Type (Trich) | active | | | 2018-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.3282.json | Specimen Collection Method | active | | | 2010-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.3020.json | Specimen Source (PHLIP) | active | | | 2008-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.6046.json | Specimen Type (HL7) | active | | | 2012-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.946.json | Specimen | active | | | 2019-12 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7921.json | Specimen type (ARLN) | active | | | 2019-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7627.json | Specimen Collection Source (FDD) | active | | | 2018-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7802.json | Specimen Type (Listeria) | active | | | 2018-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7616.json | Specimen From Mother Or Infant (CRS) | active | | | 2017-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.3141.json | Specimen Source (VPD) | active | | | 2008-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7656.json | Specimen Source (Rubella) | active | | | 2017-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7813.json | Specimen Source (CP-CRE) | active | | | 2018-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.3.20.json | Specimen Source Site (Anthrax) | active | | | 2020-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.3140.json | Specimen Source (CRS) | active | | | 2008-01 | | |
| hl7.fhir.us.mcode | R4 | ValueSet/ValueSet-mcode-human-specimen-type-vs.json | Human Specimen Type Value Set | active | 1 | cic | 2025-02 | hl7 | 1 |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.1047.json | Specimen Treatment | active | | | 2008-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7774.json | Specimen Type (RIBD) | active | | | 2019-01 | | |
| hl7.fhir.us.mcode | R4 | ValueSet/ValueSet-mcode-clin-or-path-modifier-vs.json | Clinical or Pathologic Modifier | active | | cic | 2025-02 | hl7 | 1 |
| hl7.fhir.us.mcode | R4 | ValueSet/ValueSet-mcode-lymphoma-stage-value-vs.json | Lymphoma Stage Value Set | active | | cic | 2025-02 | hl7 | 1 |
| hl7.fhir.us.mcode | R4 | ValueSet/ValueSet-mcode-lymphoma-staging-method-vs.json | Lymphoma Staging System Value Set | active | | cic | 2025-02 | hl7 | 1 |
| hl7.fhir.us.mcode | R4 | ValueSet/ValueSet-mcode-tnm-staging-method-vs.json | TNM Staging Method Value Set | active | | cic | 2025-02 | hl7 | 4 |
| hl7.fhir.us.mcode | R4 | ValueSet/ValueSet-mcode-figo-staging-method-vs.json | FIGO Staging Method Value Set | active | | cic | 2025-02 | hl7 | |
| hl7.fhir.us.mcode | R4 | ValueSet/ValueSet-mcode-lymphoma-stage-value-modifier-vs.json | Lymphoma Stage Value Modifier Value Set | active | | cic | 2025-02 | hl7 | 1 |
| hl7.fhir.us.mcode | R4 | ValueSet/ValueSet-mcode-cancer-staging-method-vs.json | Cancer Staging Method Value Set | active | 4 | cic | 2025-02 | hl7 | 2 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/ValueSet-oncology-StainingIntensityVS.json | BC StainingIntensityVS ValueSet | draft | | | 2018-08 | hl7 | 4 |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.2074.1.1.2.json | Pt Immunization Registry Status Excluding Nulls | active | | | 2012-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.830.json | State | active | | | 2008-01 | | |
| fhir.outburn.co.il | R4 | ValueSet/ValueSet-vs-condition-clinical-status.json | Condition Clinical Status | draft | | | | hl7 | 4 |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7829.json | Series Status (IIS) | active | | | 2018-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.1036.json | Referral Status (CRA) | active | | | 2008-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7231.json | Result Status (NND) | active | | | 2020-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.3600.json | Stay Period Hepatitis (NETSS) | active | | | 2011-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.3321.json | Sterile Specimen (IPD) | active | | | 2010-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-1.3.6.1.4.1.19376.1.7.3.1.1.13.8.38.json | Glucocortico Steroids (NCHS) | active | | | 2014-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7812.json | Case Type (CP-CRE) | active | | | 2018-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7752.json | Strength of Link (TB) | active | | | 2017-12 | | |
| hl7.fhir.us.registry-protocols | R4 | ValueSet/ValueSet-StressTestResults.json | Stress Test Results | active | | cic | 2023-11 | hl7 | |
| hl7.fhir.us.registry-protocols | R4 | ValueSet/ValueSet-StressTestRiskExtentofIschemia.json | Stress Test Risk/Extent of Ischemia | active | | cic | 2023-11 | hl7 | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7536.json | Height Unit (CDC) | active | | | 2016-01 | | |
| hl7.fhir.us.registry-protocols | R4 | ValueSet/ValueSet-SubmissionType.json | Submission Type | active | | cic | 2023-11 | hl7 | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.3597.json | Identifier Type (Syndromic Surveillance) | active | | | 2011-01 | | |
| hl7.fhir.us.pacio-pfe | R4 | ValueSet/ValueSet-pfe-us-core-category-vs.json | Personal Functioning and Engagement US Core Value Set | trial-use | 3 | pc | 2026-03 | hl7 | 2 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/ValueSet-substance-classification.json | Substance Classification | trial-use | 2 | brr | 2025-07 | hl7 | 5 |
| bha-test-ig | R4 | ValueSet/ValueSet-bha-substance-use-primary-vs.json | BHA Primary Substance Use Codes Value Set | draft | | | 2026-03 | | |
| bha-ig | R4 | ValueSet/ValueSet-bha-substance-use-primary-vs.json | BHA Primary Substance Use Codes Value Set | trial-use | 0 | | 2026-03 | | |
| bha-test-ig | R4 | ValueSet/ValueSet-bha-substance-use-secondary-tertiary-vs.json | BHA Secondary and Tertiary Substance Use Codes Value Set | draft | | | 2026-03 | | |
| bha-ig | R4 | ValueSet/ValueSet-bha-substance-use-secondary-tertiary-vs.json | BHA Secondary and Tertiary Substance Use Codes Value Set | trial-use | 0 | | 2026-03 | | |
| bha-test-ig | R4 | ValueSet/ValueSet-bha-substance-use-route-of-administration-vs.json | BHA Substance Use Routes of Administration Value Set | draft | | | 2026-03 | | |
| bha-ig | R4 | ValueSet/ValueSet-bha-substance-use-route-of-administration-vs.json | BHA Substance Use Routes of Administration Value Set | trial-use | 0 | | 2026-03 | | |
| hl7.fhir.us.registry-protocols | R4 | ValueSet/ValueSet-SurgicalRisk.json | SurgicalRisk | active | | cic | 2023-11 | hl7 | |
| hl7.fhir.us.ccda | R4 | ValueSet/ValueSet-2.16.840.1.113883.11.20.1.1.json | SurgicalOperationNoteDocumentTypeCode | trial-use | | cgp | 2018-05 | hl7 | 1 |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7761.json | Susceptibility Test Interpretation (TB) | active | | | 2018-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7762.json | Susceptibility Test Method (TB) | active | | | 2017-12 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7760.json | Susceptibility Test Type (TB) | active | | | 2022-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.3336.json | Susceptibility Result (IPD) | draft | | | | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.3103.json | Suspected Food Consumed (FDD) | active | | | 2008-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.3104.json | Swimming Pool Type (FDD) | active | | | 2008-01 | | |
| hl7.fhir.us.registry-protocols | R4 | ValueSet/ValueSet-SyntaxScore.json | Syntax Score for the PCI procedure | active | | cic | 2023-11 | hl7 | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7229.json | Syphilis Treatment Infant (CS) | active | | | 2020-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7221.json | Syphilis Treatment Mother (CS) | active | | | 2020-01 | | |
| hl7.fhir.us.vrdr | R4 | ValueSet/ValueSet-vrdr-system-reject-vs.json | System Reject ValueSet | active | | pher | 2024-10 | hl7 | 2 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.193.json | Conditions Associated with Head and Neck Radiotherapy | active | | | 2017-03 | hl7 | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.3156.json | Reporting Area (TB) | active | | | 2008-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.995.json | Health Care Practice Type (TB) | active | | | 2008-01 | | |
| fhir.outburn.co.il | R4 | ValueSet/ValueSet-vs-loinc-tbd.json | TBD LOINC Codes | draft | | | | hl7 | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7512.json | City Places (NCHS) | active | | | 2017-01 | | |
| hl7.fhir.us.registry-protocols | R4 | ValueSet/ValueSet-TIMIFlow.json | TIMI Flow | active | | cic | 2023-11 | hl7 | |
| fhir.r4.wales.test | R4 | ValueSet/ValueSet-DataStandardsWales-EncounterType.json | Data Standards Wales Encounter Type | active | | | 2025-09 | hl7 | 1 |
| hl7.fhir.us.pco | R4 | ValueSet/ValueSet-prom-target-measures.json | PROM Target Measure Scores | trial-use | 2 | pc | 2026-04 | hl7 | 2 |
| hl7.fhir.us.codex-radiation-therapy | R4 | ValueSet/ValueSet-codexrt-radiotherapy-free-breathing-motion-mgmt-technique-vs.json | Radiotherapy Free-Breathing Motion Management Technique Value Set | trial-use | | cgp | 2026-02 | hl7 | 1 |
| signal.core.r4 | R4 | ValueSet/valueset-telecom-contact-point-system.json | ContactPointSystem | draft | 0 | fhir | 2019-10 | hl7 | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7790.json | Heated Food (Listeria) | active | | | 2018-01 | | |
| hl7.fhir.us.vitals | R4 | ValueSet/ValueSet-MeasurementProtocolVS.json | Measurement Protocol value set | draft | | | 2024-10 | hl7 | 1 |
| hl7.fhir.us.cardx-htn | R4 | ValueSet/ValueSet-MeasurementProtocolVS.json | Measurement Protocol value set | draft | | | 2023-08 | hl7 | 1 |
| hl7.fhir.us.pco | R4 | ValueSet/ValueSet-goal-barrier-codes.json | Goal Barrier Assessment Codes | trial-use | 2 | pc | 2026-04 | hl7 | 1 |
| hl7.fhir.us.pco | R4 | ValueSet/ValueSet-readiness-assessment-codes.json | Readiness Assessment Codes | trial-use | 2 | pc | 2026-04 | hl7 | 1 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/ValueSet-spl-pharmaceutical-dosage-form-terminology.json | Pharmaceutical Dosage Form Terminology | trial-use | 2 | brr | 2025-07 | hl7 | 4 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/ValueSet-spl-drug-route-of-administration-terminology.json | Drug Route Of Administration Terminology | trial-use | 2 | brr | 2025-07 | hl7 | 4 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/ValueSet-pqcmc-name-part-terminology.json | PQCMC Name Part Terminology | trial-use | 2 | brr | 2025-07 | hl7 | 4 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/ValueSet-pqcmc-batch-utilization-terminology.json | Batch utilization Terminology | trial-use | 2 | brr | 2025-07 | hl7 | 1 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/ValueSet-pqcmc-chemical-structure-datafile-type-terminology.json | Chemical Structure Data File Type Terminology | trial-use | 2 | brr | 2025-07 | hl7 | 4 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/ValueSet-pqcmc-closure-type-terminology.json | Closure Type Terminology | trial-use | 2 | brr | 2025-07 | hl7 | 1 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/ValueSet-pqcmc-container-type-terminology.json | Container Type Terminology | trial-use | 2 | brr | 2025-07 | hl7 | 1 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/ValueSet-pqcmc-drug-product-component-function-category-terminology.json | Drug Product Component Function Category Terminology | trial-use | 2 | brr | 2025-07 | hl7 | 2 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/ValueSet-pqcmc-excipient-function-terminology.json | Excipient Function Terminology | trial-use | 2 | brr | 2025-07 | hl7 | 1 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/ValueSet-pqcmc-impurity-classification-terminology.json | Impurity Classification Terminology | trial-use | 2 | brr | 2025-07 | hl7 | 1 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/ValueSet-pqcmc-quality-benchmark-terminology.json | Quality Benchmark Terminology | trial-use | 2 | brr | 2025-07 | hl7 | 4 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/ValueSet-pqcmc-source-type-terminology.json | Source Type Terminology | trial-use | 2 | brr | 2025-07 | hl7 | 2 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/ValueSet-pqcmc-specification-status-terminology.json | Specification Status Terminology | trial-use | 2 | brr | 2025-07 | hl7 | 1 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/ValueSet-pqcmc-specification-type-terminology.json | Specification Type Terminology | trial-use | 2 | brr | 2025-07 | hl7 | 1 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/ValueSet-pqcmc-strength-type-terminology.json | Strength Type Terminology | trial-use | 2 | brr | 2025-07 | hl7 | 2 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/ValueSet-pqcmc-test-category-terminology.json | Test Category Terminology | trial-use | 2 | brr | 2025-07 | hl7 | 1 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/ValueSet-pqcmc-test-method-origin-terminology.json | Test Method Origin Terminology | trial-use | 2 | brr | 2025-07 | hl7 | 1 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/ValueSet-pqcmc-test-usage-terminology.json | Test Usage Terminology | trial-use | 2 | brr | 2025-07 | hl7 | 1 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/ValueSet-pqcmc-manufactured-dose-form-terminology.json | Manufactured Dose Form Terminology | trial-use | 2 | brr | 2025-07 | hl7 | 2 |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/ValueSet-pqcmc-units-of-measure.json | Units Of Measure | trial-use | 2 | brr | 2025-07 | hl7 | 5 |
| fhir.nwgenomics.nhs.uk | R4 | ValueSet/ValueSet-GenomicTestOutcomeCodes.json | Genomic Test Outcome Codes | draft | | | 2026-03 | hl7 | 2 |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.8004.json | Test Results (Brucellosis) | active | | | 2020-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7976.json | Test Titer Type (Brucellosis) | active | | | 2020-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7623.json | Test Method (FDD) | active | | | 2020-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7917.json | CPO PCR method (ARLN) | active | | | 2019-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7918.json | CPO AST method (ARLN) | active | | | 2019-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7916.json | CPO phenotypic method (ARLN) | active | | | 2019-01 | | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.319.json | Steward Transfer Test | active | | | 2024-07 | hl7 | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7626.json | Test Result (FDD) | active | | | 2018-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.8039.json | Test Results (Leptospirosis) | active | | | 2021-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7625.json | Test Type (FDD) | active | | | 2020-01 | | |
| signal.core.r4 | R4 | ValueSet/valueset-questionnaire-ccars-mental-health-services-program.json | Questionnaire CCARS Mental Health Services Program | draft | 1 | pa | | hl7 | |
| hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/ValueSet-pqcmc-genc-and-iso-intersect.json | GENC and ISO 3166 Intersection | trial-use | 2 | brr | 2025-07 | hl7 | 2 |
| hl7.fhir.us.carin-bb | R4 | ValueSet/ValueSet-ADAUniversalNumberingSystem.json | American Dental Association Universal Numbering Value Set | trial-use | 2 | fm | 2026-03 | hl7 | 1 |
| fhir.argonaut.clinicalnotes | R3 | ValueSet/ValueSet-diagnosticreport-category.json | Argonaut DiagnosticReport Category Value Set | draft | | | 2018-05 | hl7 | 1 |
| fhir.argonaut.clinicalnotes | R3 | ValueSet/ValueSet-documentreference-category.json | Argonaut DocumentReferences Category Value Set | draft | | | 2018-05 | hl7 | 1 |
| fhir.argonaut.clinicalnotes | R3 | ValueSet/ValueSet-argonaut-clinical-note-type.json | Argonaut DocumentReferences Type Value Set | draft | | | 2018-05 | hl7 | |
| fhir.argonaut.scheduling | R3 | ValueSet/ValueSet-visit-type.json | Argonaut Visit Types | active | | | 2017-07 | hl7 | 4 |
| fhir.ph.core | R4 | ValueSet/ValueSet-barangays.json | Barangays | draft | | | 2026-04 | hl7 | 1 |
| hl7.fhir.us.dapl | R4 | ValueSet/ValueSet-dapl-birthsex-codes.json | DAPL Birth Sex Codes | trial-use | 1 | cgp | 2026-03 | hl7 | 1 |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.826.json | Manufacturers of vaccines (MVX) | active | | | 2022-01 | | |
| ca.on.oh-dhdr | R4 | ValueSet/EncounterPriority.json | Encounter Priority | active | | | | hl7 | 3 |
| hl7.fhir.us.darts | R4 | ValueSet/ValueSet-darts-policy-identifier-codes.json | DARTS Policy Identifer Codes | trial-use | 1 | cgp | 2026-03 | hl7 | |
| hl7.fhir.us.davinci-atr | R4 | ValueSet/ValueSet-atr-changetype.json | DaVinci ATR Change Types | trial-use | 2 | fm | 2020-09 | hl7 | 2 |
| hl7.fhir.us.davinci-atr | R4 | ValueSet/ValueSet-atr-attribution-list-status.json | DaVinci Attribution List Status | trial-use | 2 | fm | 2020-09 | hl7 | 2 |
| hl7.fhir.us.davinci-atr | R4 | ValueSet/ValueSet-davinci-group-characteristic.json | DaVinci Group Characteristic | trial-use | 2 | fm | 2020-09 | hl7 | 1 |
| hl7.fhir.us.carin-bb | R4 | ValueSet/ValueSet-FDANationalDrugCode.json | National Drug Code (NDC) Value Set | trial-use | 2 | fm | 2026-03 | hl7 | 1 |
| hl7.fhir.us.davinci-pdex | R4 | ValueSet/ValueSet-FDANationalDrugCode.json | FDA National Drug Code (NDC) | informative | | fm | 2026-04 | hl7 | 1 |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7776.json | Emergency Severity Index - Acuity | active | | | 2018-01 | | |
| hl7.fhir.us.davinci-pct | R4 | ValueSet/ValueSet-PCTGFEItemNDCVS.json | PCT GFE Item NDC Value Set | trial-use | 2 | fm | 2026-03 | hl7 | 1 |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.6039.json | Funding Eligibility Observation Method (IIS) | active | | | 2012-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.88.12.80.64.json | Medication Fill Status Value Set | active | | | 2009-01 | | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.4.642.2.575.json | Race Categories | active | | | 2025-04 | hl7 | 2 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.4.642.40.2.48.3.json | Ethnicity Categories | active | | | 2025-04 | hl7 | 2 |
| hl7.fhir.us.vitals | R4 | ValueSet/ValueSet-NumericResultIntNonPanicVS.json | Numeric Result Interpretation without panic values, value set | draft | | | 2024-10 | hl7 | 5 |
| hl7.fhir.us.vitals | R4 | ValueSet/ValueSet-NumericResultIntVS.json | Numeric Result Interpretation value set | draft | | | 2024-10 | hl7 | 4 |
| hl7.fhir.us.cardx-htn | R4 | ValueSet/ValueSet-NumericResultIntVS.json | Numeric Result Interpretation value set | draft | | | 2023-08 | hl7 | 4 |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.88.12.3221.3.2.json | Contact Type Value Set | active | | | 2009-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.1066.json | Healthcare Provider Taxonomy (HIPAA) | active | | | 2008-01 | | |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.113883.11.19465.json | Healthcare Provider Taxonomy Code (NUCC) | active | | | 2019-01 | | |
| hl7.fhir.us.covid19library | R4 | ValueSet/ValueSet-iso-state-codes-value-set.json | ISO Code System 3166 state/province codes. | active | | | 2022-07 | hl7 | 1 |
| hl7.fhir.us.covid19library | R4 | ValueSet/ValueSet-iso-country-codes-value-set.json | ISO Code System 3166 country codes | active | | | 2022-07 | hl7 | 1 |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7900.json | Industry NAICS Detail (ODH) | active | | | 2020-01 | | 4 |
| hl7.fhir.us.cqfmeasures | R4 | ValueSet/ValueSet-intended-venue.json | Intended Venue | active | | cqi | 2025-08 | hl7 | 1 |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-1.3.6.1.4.1.33895.1.3.0.75.json | Joint Commission Medical Reason | active | | | 2010-01 | | |
| hl7.fhir.us.codex-radiation-therapy | R4 | ValueSet/ValueSet-codexrt-radiotherapy-adverse-event-termVS.json | Adverse Event Terms Value Set | trial-use | | cgp | 2026-02 | hl7 | 1 |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.1100.json | Industry (NAICS) | active | | | 2008-01 | | |
| hl7.fhir.us.davinci-pdex | R4 | ValueSet/ValueSet-MtlsObjectTypeVS.json | mTLS Signed Object Types | trial-use | 2 | fm | 2026-04 | hl7 | 1 |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.7901.json | Occupation ONETSOC Detail (ODH) | active | | | 2020-01 | | 5 |
| fhir.ph.core | R4 | ValueSet/ValueSet-occupational-classifications.json | Occupation Classifications | draft | | | 2026-04 | hl7 | 1 |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-admitting-source-facility-type.json | PCORNet Admitting Source Facility Type | active | | | 2021-09 | hl7 | 2 |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-body-position.json | PCORNet BP Position | active | | | 2021-09 | hl7 | 2 |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-birth-sex.json | PCORNet Birth Sex | active | | | 2021-09 | hl7 | 1 |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-clinical-status.json | PCORNet Clinical Status | active | | | 2021-09 | hl7 | 1 |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-condition-source.json | PCORNet Condition Source | active | | | 2021-09 | hl7 | 2 |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-death-cause-code.json | PCORNet Death Cause Code | active | | | 2021-09 | hl7 | 2 |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-death-cause-type.json | PCORNet Death Cause Type | active | | | 2021-09 | hl7 | 2 |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-death-confidence-code.json | PCORNet Death Confidence Code | active | | | 2021-09 | hl7 | 3 |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-death-source.json | PCORNet Death Source | active | | | 2021-09 | hl7 | 3 |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-diagnosis-classification.json | PCORNet Diagnosis Classification | active | | | 2021-09 | hl7 | 1 |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-drg-group-version.json | PCORNet DRG Group Version | active | | | 2021-09 | hl7 | 2 |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-discharge-disposition.json | PCORNet Discharge Disposition | active | | | 2021-09 | hl7 | 1 |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-discharge-status.json | PCORNet Discharge Status | active | | | 2021-09 | hl7 | 2 |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-encounter-type.json | PCORNet Encounter Type | active | | | 2021-09 | hl7 | 1 |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-enr-basis.json | PCORNet Enrollment Basis | active | | | 2021-09 | hl7 | 1 |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-ethnicity.json | PCORNet Ethnicity | active | | | 2021-09 | hl7 | 2 |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-facility-type.json | PCORNet Facility Type | active | | | 2021-09 | hl7 | 1 |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-gender-identity.json | PCORNet Gender Identity | active | | | 2021-09 | hl7 | 1 |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-information-source-hc-subtype.json | PCORNet Information Source HC Subtype | active | | | 2021-09 | hl7 | 5 |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-lab-loinc-code-source.json | PCORNet Lab Loinc Code Source | active | | | 2021-09 | hl7 | 2 |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-lab-loinc-source.json | PCORNet Lab Loinc Source | active | | | 2021-09 | hl7 | |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-lab-test-priority.json | PCORNet Lab Test Priority | active | | | 2021-09 | hl7 | 2 |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-race.json | PCORNet Race | active | | | 2021-09 | hl7 | 2 |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-sexual-orientation.json | PCORNet Sexual Orientation | active | | | 2021-09 | hl7 | 1 |
| hl7.fhir.us.cdmh | R4 | ValueSet/ValueSet-pcornet-vital-source.json | PCORNet Vital Source | active | | | 2021-09 | hl7 | 2 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.11.20.9.36.json | Pressure Point | active | | | 2024-06 | hl7 | 1 |
| hl7.fhir.us.resp-net | R4 | ValueSet/ValueSet-respnet-report-context-codes.json | RESP-NET Report Context Codes | trial-use | 2 | pher | 2020-09 | hl7 | 1 |
| us.cdc.phinvads | R4 | ValueSet/ValueSet-2.16.840.1.114222.4.11.3588.json | Method of Race and Ethnicity Data Collection | active | | | 2010-01 | | |
| fhir.ph.core | R4 | ValueSet/ValueSet-regions.json | Regions | draft | | | 2026-04 | hl7 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1018.98.json | Route of Administration | active | | | 2019-05 | hl7 | |